![Nic G. Scalfarotto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nic G.
Scalfarotto held former positions as Vice President-Regulatory Affairs at Momenta Pharmaceuticals, Inc., Senior Vice President-Regulatory Affairs at Aegerion Pharmaceuticals, Inc. and Kura Oncology, Inc., and VP-Regulatory Affairs & Program Management at X4 Pharmaceuticals, Inc. He obtained an undergraduate degree from Seton Hall University and a doctorate degree from Alma Mater Studiorum - Università di Bologna.
| Empresas | Cargo | Fin |
|---|---|---|
| KURA ONCOLOGY, INC. | Consejero General | - |
| X4 PHARMACEUTICALS, INC. | Consejero General | - |
| AEGERION PHARMACEUTICALS, INC. | Consejero General | - |
| MOMENTA PHARMACEUTICALS, INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 6 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alma Mater Studiorum - Università di Bologna
 Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
